4:02PM Array Biopharma beats by $0.05, beats on revs (ARRY) 3.49 -0.13 : Reports Q1 (Mar) loss of $0.11 per share, $0.05 better than the Capital IQ Consensus Estimate of ($0.16); revenues rose 7.3% year/year to $19.1 mln vs the $18.51 mln consensus.
Market Data 
Markets 
AI
